<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.marketbeat.com/feed/</title><link>https://www.marketbeat.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Mon, 06 Oct 2025 17:29:31 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>3 Exceptional Stocks to Build Long-Term Wealth</title><link>https://www.marketbeat.com/stock-ideas/3-exceptional-stocks-to-build-long-term-wealth/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Discover three standout growth stocks with strong long-term potential, spanning space, retail, and biotech industries, poised for sustained investor r...</description><pubDate>Mon, 06 Oct 2025 17:25:00 GMT</pubDate></item><item><title>Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?</title><link>https://www.marketbeat.com/stock-ideas/insider-sales-jump-at-broadcom-and-coreweave-red-flag-ahead/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>CoreWeave and Broadcom are bringing in big returns for investors in 2025. However, with insider selling surging, should the future of these names be a...</description><pubDate>Mon, 06 Oct 2025 16:39:00 GMT</pubDate></item><item><title>Marvell Insiders Buy Shares—Should Investors Follow Suit?</title><link>https://www.insidertrades.com/education/marvell-insiders-buy-sharesshould-investors-follow-suit/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Marvell Technology insiders purchased stock after the company announced a buyback plan, affirming a robust outlook for the company's business strength...</description><pubDate>Mon, 06 Oct 2025 15:04:00 GMT</pubDate></item><item><title>Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants</title><link>https://www.marketbeat.com/stock-ideas/trumps-drug-price-cuts-boom-or-bust-for-these-3-pharma-giants/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.</description><pubDate>Mon, 06 Oct 2025 14:21:00 GMT</pubDate></item><item><title>3 Fintech Stocks That Are Set to Rise as Rates Fall</title><link>https://www.marketbeat.com/stock-ideas/3-fintech-stocks-that-are-set-to-rise-as-rates-fall/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Fed rate cuts may unlock upside for UPST, AFRM, and RKT stocks, boosting loan volumes, BNPL demand, and mortgage refinancing.</description><pubDate>Mon, 06 Oct 2025 13:01:00 GMT</pubDate></item></channel></rss>